Prevalence of Antibodies to Human Immunodeficiency Virus among Intravenous Drug Users in Israel — Association with Travel Abroad

Dan M (Infectious Disease Unit, The E Wolfson Hospital, Holon 58100, Israel), Rock M and Bar-Shany S. Prevalence of antibodies to Human Immunodeficiency Virus among intravenous drug users in Israel—association with travel abroad. International Journal of Epidemiology 1989, 18: 239–241. A serological...

Full description

Saved in:
Bibliographic Details
Published in:International journal of epidemiology 1989-03, Vol.18 (1), p.239-241
Main Authors: DAN, MICHAEL, ROCK, MEIR, BAR-SHANY, SHULAMIT
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Europe
Female
HIV Seropositivity - epidemiology
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Injections, Intravenous
Israel
Male
Medical sciences
Middle Aged
Substance-Related Disorders - complications
Travel
United States
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c384t-6e3f7d2ce3c73cce6e0643852442328fa1c57566fe145988aca9f847ebf740593
cites
container_end_page 241
container_issue 1
container_start_page 239
container_title International journal of epidemiology
container_volume 18
creator DAN, MICHAEL
ROCK, MEIR
BAR-SHANY, SHULAMIT
description Dan M (Infectious Disease Unit, The E Wolfson Hospital, Holon 58100, Israel), Rock M and Bar-Shany S. Prevalence of antibodies to Human Immunodeficiency Virus among intravenous drug users in Israel—association with travel abroad. International Journal of Epidemiology 1989, 18: 239–241. A serological survey of 400 Israeli intravenous drug users showed a 2% prevalence of antibodies to human immunodeficiency virus (HIV). No difference was found between seropositive and seronegative subjects regarding mean age, duration of intravenous drug use, and needle sharing. Seropositivity was, however, significantly associated with travel abroad since 1980 (P
doi_str_mv 10.1093/ije/18.1.239
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15308491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15308491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-6e3f7d2ce3c73cce6e0643852442328fa1c57566fe145988aca9f847ebf740593</originalsourceid><addsrcrecordid>eNo9kM1uEzEURi0EKqGwY4vkBeqqk_pvxp5l1FISqQgQKaBuLMdzXVxm7GLPFLpDPANPyJPgKlFWV7rf-a6uDkIvKZlT0vITfwMnVM3pnPH2EZpR0YiKN6p-jGaEE1LVUtKn6FnON4RQIUR7gA6YZIxLOkN_PiS4Mz0ECzg6vAij38TOQ8ZjxMtpMAGvhmEKsQPnrS_cPf7s05SxGWK4xqswJnMHIZbNWZqu8WWGlLEvtZwM9Pjf7794kXO03ow-BvzTj9_w-qHT48UmRdM9R0-c6TO82M1DdHn-Zn26rC7ev12dLi4qy5UYqwa4kx2zwK3k1kIDpBFc1UwIxplyhtpa1k3jgIq6VcpY0zolJGycFKRu-SE62t69TfHHBHnUg88W-t4EKO9rWnOiREsLeLwFbYo5J3D6NvnBpHtNiX5QrotyTZWmuigv-Kvd3WkzQLeHd45L_nqXm2xN75IJ1uc9JhlXTKiCVVvM5xF-7WOTvutGclnr5dcr_W5Nzj5efSL6C_8PnrCazA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15308491</pqid></control><display><type>article</type><title>Prevalence of Antibodies to Human Immunodeficiency Virus among Intravenous Drug Users in Israel — Association with Travel Abroad</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>DAN, MICHAEL ; ROCK, MEIR ; BAR-SHANY, SHULAMIT</creator><creatorcontrib>DAN, MICHAEL ; ROCK, MEIR ; BAR-SHANY, SHULAMIT</creatorcontrib><description>Dan M (Infectious Disease Unit, The E Wolfson Hospital, Holon 58100, Israel), Rock M and Bar-Shany S. Prevalence of antibodies to Human Immunodeficiency Virus among intravenous drug users in Israel—association with travel abroad. International Journal of Epidemiology 1989, 18: 239–241. A serological survey of 400 Israeli intravenous drug users showed a 2% prevalence of antibodies to human immunodeficiency virus (HIV). No difference was found between seropositive and seronegative subjects regarding mean age, duration of intravenous drug use, and needle sharing. Seropositivity was, however, significantly associated with travel abroad since 1980 (P&lt;0.001), and with intravenous drug injection abroad (P = 0.04). These data indicate that Israel is a pre-endemic area for HIV infection, and transmission of the virus among Israeli intravenous drug users seems to be infrequent at the current level of exposure.</description><identifier>ISSN: 0300-5771</identifier><identifier>EISSN: 1464-3685</identifier><identifier>DOI: 10.1093/ije/18.1.239</identifier><identifier>PMID: 2722371</identifier><identifier>CODEN: IJEPBF</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Biological and medical sciences ; Europe ; Female ; HIV Seropositivity - epidemiology ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Injections, Intravenous ; Israel ; Male ; Medical sciences ; Middle Aged ; Substance-Related Disorders - complications ; Travel ; United States</subject><ispartof>International journal of epidemiology, 1989-03, Vol.18 (1), p.239-241</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-6e3f7d2ce3c73cce6e0643852442328fa1c57566fe145988aca9f847ebf740593</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7238248$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2722371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DAN, MICHAEL</creatorcontrib><creatorcontrib>ROCK, MEIR</creatorcontrib><creatorcontrib>BAR-SHANY, SHULAMIT</creatorcontrib><title>Prevalence of Antibodies to Human Immunodeficiency Virus among Intravenous Drug Users in Israel — Association with Travel Abroad</title><title>International journal of epidemiology</title><addtitle>Int J Epidemiol</addtitle><description>Dan M (Infectious Disease Unit, The E Wolfson Hospital, Holon 58100, Israel), Rock M and Bar-Shany S. Prevalence of antibodies to Human Immunodeficiency Virus among intravenous drug users in Israel—association with travel abroad. International Journal of Epidemiology 1989, 18: 239–241. A serological survey of 400 Israeli intravenous drug users showed a 2% prevalence of antibodies to human immunodeficiency virus (HIV). No difference was found between seropositive and seronegative subjects regarding mean age, duration of intravenous drug use, and needle sharing. Seropositivity was, however, significantly associated with travel abroad since 1980 (P&lt;0.001), and with intravenous drug injection abroad (P = 0.04). These data indicate that Israel is a pre-endemic area for HIV infection, and transmission of the virus among Israeli intravenous drug users seems to be infrequent at the current level of exposure.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Europe</subject><subject>Female</subject><subject>HIV Seropositivity - epidemiology</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Injections, Intravenous</subject><subject>Israel</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Substance-Related Disorders - complications</subject><subject>Travel</subject><subject>United States</subject><issn>0300-5771</issn><issn>1464-3685</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNo9kM1uEzEURi0EKqGwY4vkBeqqk_pvxp5l1FISqQgQKaBuLMdzXVxm7GLPFLpDPANPyJPgKlFWV7rf-a6uDkIvKZlT0vITfwMnVM3pnPH2EZpR0YiKN6p-jGaEE1LVUtKn6FnON4RQIUR7gA6YZIxLOkN_PiS4Mz0ECzg6vAij38TOQ8ZjxMtpMAGvhmEKsQPnrS_cPf7s05SxGWK4xqswJnMHIZbNWZqu8WWGlLEvtZwM9Pjf7794kXO03ow-BvzTj9_w-qHT48UmRdM9R0-c6TO82M1DdHn-Zn26rC7ev12dLi4qy5UYqwa4kx2zwK3k1kIDpBFc1UwIxplyhtpa1k3jgIq6VcpY0zolJGycFKRu-SE62t69TfHHBHnUg88W-t4EKO9rWnOiREsLeLwFbYo5J3D6NvnBpHtNiX5QrotyTZWmuigv-Kvd3WkzQLeHd45L_nqXm2xN75IJ1uc9JhlXTKiCVVvM5xF-7WOTvutGclnr5dcr_W5Nzj5efSL6C_8PnrCazA</recordid><startdate>19890301</startdate><enddate>19890301</enddate><creator>DAN, MICHAEL</creator><creator>ROCK, MEIR</creator><creator>BAR-SHANY, SHULAMIT</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>19890301</creationdate><title>Prevalence of Antibodies to Human Immunodeficiency Virus among Intravenous Drug Users in Israel — Association with Travel Abroad</title><author>DAN, MICHAEL ; ROCK, MEIR ; BAR-SHANY, SHULAMIT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-6e3f7d2ce3c73cce6e0643852442328fa1c57566fe145988aca9f847ebf740593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Europe</topic><topic>Female</topic><topic>HIV Seropositivity - epidemiology</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Injections, Intravenous</topic><topic>Israel</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Substance-Related Disorders - complications</topic><topic>Travel</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DAN, MICHAEL</creatorcontrib><creatorcontrib>ROCK, MEIR</creatorcontrib><creatorcontrib>BAR-SHANY, SHULAMIT</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>International journal of epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DAN, MICHAEL</au><au>ROCK, MEIR</au><au>BAR-SHANY, SHULAMIT</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Antibodies to Human Immunodeficiency Virus among Intravenous Drug Users in Israel — Association with Travel Abroad</atitle><jtitle>International journal of epidemiology</jtitle><addtitle>Int J Epidemiol</addtitle><date>1989-03-01</date><risdate>1989</risdate><volume>18</volume><issue>1</issue><spage>239</spage><epage>241</epage><pages>239-241</pages><issn>0300-5771</issn><eissn>1464-3685</eissn><coden>IJEPBF</coden><abstract>Dan M (Infectious Disease Unit, The E Wolfson Hospital, Holon 58100, Israel), Rock M and Bar-Shany S. Prevalence of antibodies to Human Immunodeficiency Virus among intravenous drug users in Israel—association with travel abroad. International Journal of Epidemiology 1989, 18: 239–241. A serological survey of 400 Israeli intravenous drug users showed a 2% prevalence of antibodies to human immunodeficiency virus (HIV). No difference was found between seropositive and seronegative subjects regarding mean age, duration of intravenous drug use, and needle sharing. Seropositivity was, however, significantly associated with travel abroad since 1980 (P&lt;0.001), and with intravenous drug injection abroad (P = 0.04). These data indicate that Israel is a pre-endemic area for HIV infection, and transmission of the virus among Israeli intravenous drug users seems to be infrequent at the current level of exposure.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>2722371</pmid><doi>10.1093/ije/18.1.239</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0300-5771
ispartof International journal of epidemiology, 1989-03, Vol.18 (1), p.239-241
issn 0300-5771
1464-3685
language eng
recordid cdi_proquest_miscellaneous_15308491
source Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Adult
Biological and medical sciences
Europe
Female
HIV Seropositivity - epidemiology
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Injections, Intravenous
Israel
Male
Medical sciences
Middle Aged
Substance-Related Disorders - complications
Travel
United States
title Prevalence of Antibodies to Human Immunodeficiency Virus among Intravenous Drug Users in Israel — Association with Travel Abroad
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A26%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Antibodies%20to%20Human%20Immunodeficiency%20Virus%20among%20Intravenous%20Drug%20Users%20in%20Israel%20%E2%80%94%20Association%20with%20Travel%20Abroad&rft.jtitle=International%20journal%20of%20epidemiology&rft.au=DAN,%20MICHAEL&rft.date=1989-03-01&rft.volume=18&rft.issue=1&rft.spage=239&rft.epage=241&rft.pages=239-241&rft.issn=0300-5771&rft.eissn=1464-3685&rft.coden=IJEPBF&rft_id=info:doi/10.1093/ije/18.1.239&rft_dat=%3Cproquest_cross%3E15308491%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-6e3f7d2ce3c73cce6e0643852442328fa1c57566fe145988aca9f847ebf740593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15308491&rft_id=info:pmid/2722371&rfr_iscdi=true